Key Metrics
8.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.99
5-Year SI
5-year SI
- N/A 2-year SI
- 0.95 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
0.83
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Reactive oxygen species
- Lung cancer
- Camptothecin
- Drug delivery
- Breast cancer
- Nanomedicine
- Assay
- Doxorubicin
- Bioavailability
- Extracellular vesicles
- Autophagy
- Nanocarriers
- Iron oxide nanoparticles
- Tumor microenvironment
- Neuroscience research
- Bilirubin
- Glioblastoma
- Photodynamic therapy
- Rheumatoid arthritis
- Gemcitabine
Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Nanomedicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Harnessing the power of targeted metal nanocarriers mediated photodynamic and photothermal therapy.
- 15 Nov 24
- Nanomedicine (London, England)
-
Full paper
Recent advances in polymeric and lipid stimuli-responsive nanocarriers for cell-based cancer immunotherapy.
- 14 Nov 24
- Nanomedicine (London, England)
-
Full paper
Lipid-based nanosystems: a pivotal solution in drug delivery.
- 14 Nov 24
- Nanomedicine (London, England)
-
Full paper
The potential of nanoparticle-based contrast agents in the diagnosis of neurodegenerative pathologies.
- 14 Nov 24
- Nanomedicine (London, England)
-
Full paper
Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations.
- 13 Nov 24
- Nanomedicine (London, England)
-
Full paper
Niosomal gel improves dermal delivery of nimbolide: a promising approach for treatment of psoriasis.
- 12 Nov 24
- Nanomedicine (London, England)
Scite analysis
Powered by scite_
3.3k articles received 84.8k citations see all
- 1,783 Supporting
- 82,158 Mentioning
- 84 Contrasting
Editorial notices
- 7 Retractions
- 0 Withdrawals
- 23 Corrections
- 17 Errata
- 0 Expression of Concern
FAQs
How long has Nanomedicine been actively publishing?
Nanomedicine has been in operation since 2006 till date.
What is the publishing frequency of Nanomedicine ?
Nanomedicine published with a Semi-monthly frequency.
How many articles did Nanomedicine publish last years ?
In 2023, Nanomedicine published 150 articles.
What is the eISSN & pISSN for Nanomedicine ?
For Nanomedicine,eISSN is 1748-6963 and pISSN is1743-5889.
What is Citescore for Nanomedicine ?
Citescore for Nanomedicine is 8.3.
What is SNIP score for Nanomedicine ?
SNIP score for Nanomedicine is 0.83.
Who is the publisher of Nanomedicine ?
FUTURE MEDICINE LTD is the publisher of Nanomedicine.